Rocket Pharmaceuticals RCKT
NASDAQ RCKT
$2.48 +0.03 (+1.22%)
At close: Nov 11, 2026 · 4:00 PM EST

Rocket Pharmaceuticals (RCKT) Notes Payables (2013 - 2021)

Updated

Rocket Pharmaceuticals' Notes Payables was $5.1 million in Q2 2021, up 2.3% from the prior quarter.

Analysis

Rocket Pharmaceuticals (RCKT) Notes Payables (2013 - 2021) Analysis & Trends

At the end of FY2020, Notes Payables at Rocket Pharmaceuticals came in at $4.88 million.

  • Per Business Quant data, RCKT's Notes Payables in the three quarters before Q2 2021 was $4.99 million (Q1 2021), $4.88 million (Q4 2020) and $4.77 million (Q3 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Rocket Pharmaceuticals 268.37 Mn -15.33 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 5.10 Mn
Mar 31, 2021 4.99 Mn
Dec 31, 2020 4.88 Mn
Sep 30, 2020 4.77 Mn
Dec 31, 2014 3.06 Mn
Dec 31, 2013 1.41 Mn
API Access

Rocket Pharmaceuticals Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=RCKT&period=max&api_key=YOUR_API_KEY